RSRobert H. Shaw
Robert H. Shaw
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert H. Shaw has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Samuel Provstgaard-Morys
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
2 shared publicationsAdam Finn
Bristol Vaccine Centre, Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
1 shared publication- Adam Finn
University of Bristol
1 shared publication Alasdair P.S. Munro
1 shared publicationAlberto San Francisco Ramos
1 shared publicationAmisha Desai
1 shared publication
Latest Publications
- 15 November 2023
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 11 (12) , 1038-1039
Nasally delivered SARS-CoV-2 vaccines: future promise and challenges
- 15 November 2023
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 11 (12) , 1038-1039
Nasally delivered SARS-CoV-2 vaccines: future promise and challenges
- Open Access
- 5 April 2023
- Published by Elsevier in Journal of Infection
- Vol. 86 (6) , 574-583
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
- 5 April 2023
- Published by Elsevier in Journal of Infection
- Vol. 86 (6) , 574-583
Open AccessPersistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
- Open Access
- 9 June 2022
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 10 (11) , 1049-1060
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
- 9 June 2022
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 10 (11) , 1049-1060
Open AccessEffect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial